Related Experiment Video
Updated: Sep 15, 2025
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Comprehensive revenue comparison of pure robotic vs. hybrid robotic surgery for sigmoid colon and rectosigmoid cancer
Toshiyuki Fukuda1, Masakatsu Numata2, Tatsunosuke Harada1
1Gastroenterological Center, Yokohama City University Medical Center, 4-57, Urafune-Cho, Minami-Ku, Yokohama-City, Kanagawa, 232-0024, Japan.
Purpose:
Robotic surgery (RS) in colorectal procedures is growing but remains costly. This study evaluated the cost-saving potential of hybrid robotic surgery (hybrid RS), which integrates laparoscopic devices, compared to conventional RS (pure RS).
Methods:
This single-center retrospective study (2022-2024) compared pure RS and hybrid RS for sigmoid and rectosigmoid cancers. Propensity score matching minimizes bias. Total revenue is calculated as the total fee minus the total cost.
Results:
After matching, 20 patients (10 per group) were analyzed. Hybrid RS improved total revenue ($3515.15 vs. $3229.33) by reducing the total cost ($3652.45 vs. $4061.33), mainly through lower material costs for staplers and ultrasonic devices. The operative time was shorter, and the safety and pathological outcomes were comparable.
Conclusions:
Hybrid RS enhances cost efficiency by substituting expensive devices with affordable alternatives, supporting wider adoption of robotic surgery. Further validation using larger studies is necessary.
